speb/financial-data huggingface dataset:
Financial ratios for NXE — annual report dated 2023-12-31
Total revenue: 0
Operating income: -64193181.81818181
Net income: 61224242.42424242
Capital expenditures: 4595454.545454545
Operating cash flow: -39860606.06060606
Depreciation & amortization: 1366666.6666666665
Net tangible assets: 621226515.1515151
Owner earnings: 57995454.54545454
Return on net tangible assets (%): 9.335637344988347
Buffett classification: The Gruesome
Stock price: 7
P/E ratio: 75.6786162398535
Shares outstanding: 661909421
Book value: 621226515.1515151
P/B ratio: 7.458416268452316
Market cap (USD): 4633365947
Debt to equity: 0.19562961346017593
Current ratio: 1.6468962927195665
Quick ratio: 1.6468962927195665
Effective tax rate (%): -2.0536389551457326
Interest coverage ratio: -13.555431131019036
Free cash flow (dilution-adjusted): -155731060.6060606
Buyback yield (%): 0
Retained earnings: -230306060.6060606
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.320510087876889
Rule of 40 score: 0
Financial ratios for NXE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.53
Shares outstanding: 661909421
Market cap (USD): 4322268519.13
Buyback yield (%): 0.009271537364397784
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.6
Shares outstanding: 661909421
Market cap (USD): 4368602178.599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NXE — annual report dated 2024-12-31
Total revenue: 0
Operating income: -54711888.11188811
Net income: -54237062.93706294
Capital expenditures: 1651048.9510489511
Operating cash flow: -16844055.944055945
Depreciation & amortization: 1574825.174825175
Net tangible assets: 824504195.8041959
Owner earnings: -54313286.71328671
Return on net tangible assets (%): -6.587387546319423
Buffett classification: The Gruesome
Stock price: 6.6
Shares outstanding: 661909421
Book value: 824504195.8041959
P/B ratio: 5.298459608612423
Market cap (USD): 4368602178.599999
Debt to equity: 0.38735633451254026
Current ratio: 1.0315261518768655
Quick ratio: 1.0315261518768655
Interest coverage ratio: -2.399423436685374
Free cash flow (dilution-adjusted): -128883916.08391608
Buyback yield (%): 0
Retained earnings: -266827272.72727275
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.63521980575542
Rule of 40 score: 0
Financial ratios for NXE — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -11368531.468531469
Net income: -35618881.11888112
Capital expenditures: 19627272.727272727
Operating cash flow: -799300.6993006993
Depreciation & amortization: 383916.0839160839
Net tangible assets: 771616083.9160839
Owner earnings: -54862237.762237765
Return on net tangible assets (%): -7.110043311150605
Buffett classification: The Gruesome
Stock price: 4.49
Shares outstanding: 661909421
Book value: 771616083.9160838
P/B ratio: 3.8516217614422015
Market cap (USD): 2971973300.29
Debt to equity: 0.3851611049735775
Current ratio: 0.9719311799581595
Quick ratio: 0.9719311799581595
Interest coverage ratio: -1.3966494845360824
Free cash flow (dilution-adjusted): -22988811.18881119
Buyback yield (%): 0
Retained earnings: -302446153.84615386
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4696602885260368
Rule of 40 score: 0
Financial ratios for NXE — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -10910948.905109487
Net income: -63279562.043795615
Capital expenditures: 18909489.05109489
Operating cash flow: -7975912.408759124
Depreciation & amortization: 386861.3138686131
Net tangible assets: 748824087.5912408
Owner earnings: -81802189.7810219
Return on net tangible assets (%): -10.9240863290278
Buffett classification: The Gruesome
Stock price: 6.94
Shares outstanding: 661909421
Book value: 748824087.5912408
P/B ratio: 6.134486667645136
Market cap (USD): 4593651381.740001
Debt to equity: 0.4767377367337013
Current ratio: 0.7509100762225652
Quick ratio: 0.7509100762225652
Interest coverage ratio: -1.274991470487888
Free cash flow (dilution-adjusted): -29670072.99270073
Buyback yield (%): 0
Retained earnings: -378971532.8467153
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4415630756174476
Rule of 40 score: 0
Financial ratios for NXE — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -15817266.187050361
Net income: -92964028.77697842
Capital expenditures: 47558273.381294966
Operating cash flow: -7508633.093525181
Depreciation & amortization: 401438.84892086335
Net tangible assets: 661007913.6690648
Owner earnings: -140120863.30935252
Return on net tangible assets (%): -21.198061386524394
Buffett classification: The Gruesome
Stock price: 8.95
Shares outstanding: 661909421
Book value: 661007913.6690648
P/B ratio: 8.962206344954456
Market cap (USD): 5924089317.95
Debt to equity: 0.6451211959934742
Current ratio: 0.49833897980908065
Quick ratio: 0.49833897980908065
Interest coverage ratio: -1.9520554026458314
Free cash flow (dilution-adjusted): -63028057.55395684
Buyback yield (%): 0
Retained earnings: -466482014.38848925
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.368374562110316
Rule of 40 score: 0
Financial ratios for NXE — annual report dated 2025-12-31
Total revenue: 0
Operating income: -65573722.627737224
Net income: -226040875.91240874
Capital expenditures: 368613.13868613134
Operating cash flow: -34680291.97080292
Depreciation & amortization: 1605839.4160583941
Net tangible assets: 1337305109.489051
Owner earnings: -224803649.63503647
Return on net tangible assets (%): -16.81019896206992
Buffett classification: The Gruesome
Stock price: 9.2
Shares outstanding: 661909421
Book value: 1337305109.489051
P/B ratio: 4.553610563506082
Market cap (USD): 6089566673.2
Debt to equity: 0.3203473812679165
Current ratio: 1.820542025711639
Quick ratio: 1.820542025711639
Interest coverage ratio: -1.922406967537609
Free cash flow (dilution-adjusted): -198053284.6715328
Buyback yield (%): 0
Retained earnings: -504554014.5985401
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.875615788276835
Rule of 40 score: 0
Financial ratios for NXE — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -26749635.03649635
Net income: -31262043.795620434
Capital expenditures: 87280291.97080292
Operating cash flow: -18251824.817518245
Depreciation & amortization: 411678.8321167883
Net tangible assets: 1337305109.489051
Owner earnings: -118130656.93430656
Return on net tangible assets (%): -8.833485798872118
Buffett classification: The Gruesome
Stock price: 9.2
Shares outstanding: 661909421
Book value: 1337305109.489051
P/B ratio: 4.553610563506082
Market cap (USD): 6089566673.2
Debt to equity: 0.3203473812679165
Current ratio: 1.820542025711639
Quick ratio: 1.820542025711639
Interest coverage ratio: -3.0276768010575017
Free cash flow (dilution-adjusted): -80439416.05839416
Buyback yield (%): 0
Retained earnings: -504554014.5985401
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.988920831214448
Rule of 40 score: 0
Financial ratios for OGN.L — annual report dated 2021-07-31
Total revenue: 1974246428.5714285
Gross profit: 292179761.9047619
Operating income: 62416666.66666667
Net income: 45514285.71428572
Capital expenditures: 6325000
Operating cash flow: 73675000
Depreciation & amortization: 37203571.42857143
Net tangible assets: 134000000
Owner earnings: 76392857.14285715
Return on net tangible assets (%): 57.00959488272922
Capex to operating income (%): 10.13351134846462
Buffett classification: The Great
Stock price: 0.03652777777777778
P/E ratio: 0.08626430405419543
Shares outstanding: 107486916
Book value: 429767857.1428571
P/B ratio: 0.009135765079708038
Market cap (USD): 3926258.1816666666
Debt to equity: 0.6348997936316673
Current ratio: 1.1803038523384741
Quick ratio: 0.8799829526417097
Effective tax rate (%): 20.05353184726695
Interest coverage ratio: 5.609286402054135
COGS to revenue (%): 85.200441156873
SG&A to revenue (%): 11.120819456730628
Free cash flow (dilution-adjusted): 50765476.190476194
Buyback yield (%): 0
Retained earnings: 519291666.6666667
Inventory turnover: 6.595693232689606
Receivables turnover: 4.345711590367129
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.97033612668996
FCF margin (%): 2.571384982938035
Rule of 40 score: 2.571384982938035
Financial ratios for OGN.L — annual report dated 2022-07-31
Total revenue: 2389900000
Gross profit: 376698979.59183675
Operating income: 106636734.69387755
Net income: 81529591.8367347
Capital expenditures: 12290816.326530613
Operating cash flow: 130266326.53061225
Depreciation & amortization: 40091836.73469388
Net tangible assets: 153855102.04081634
Owner earnings: 109330612.24489796
Return on net tangible assets (%): 71.06076483306583
Capex to operating income (%): 11.52587460767052
Buffett classification: The Great
Stock price: 0.04402439024390244
P/E ratio: 0.05804083927678206
Shares outstanding: 107486916
Book value: 410996938.7755103
P/B ratio: 0.011513579517637823
Market cap (USD): 4732045.936097561
Debt to equity: 0.49203653634641487
Current ratio: 1.1352085126702194
Quick ratio: 0.7185862010807306
Effective tax rate (%): 23.32959092610185
Interest coverage ratio: 8.57715036112935
COGS to revenue (%): 84.23787691569368
SG&A to revenue (%): 10.649621579248043
Free cash flow (dilution-adjusted): 103316326.53061225
Buyback yield (%): 862.4866676543818
Retained earnings: 505973469.3877551
Inventory turnover: 5.186316414834442
Receivables turnover: 5.897555214777995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.43703718535278
FCF margin (%): 4.323039730976704
Revenue growth (%): 21.053783631729285
Rule of 40 score: 25.376823362705988
Financial ratios for OGN.L — annual report dated 2023-07-31
Total revenue: 2699085714.285714
Gross profit: 367185714.28571427
Operating income: 85006593.4065934
Net income: 56079120.87912088
Capital expenditures: 20145054.945054945
Operating cash flow: 137118681.3186813
Depreciation & amortization: 39237362.63736264
Net tangible assets: 121634065.93406592
Owner earnings: 75171428.57142857
Return on net tangible assets (%): 61.801295545095634
Capex to operating income (%): 23.69822638192254
Buffett classification: The Great
Stock price: 0.03551282051282051
P/E ratio: 0.06806746424596331
Shares outstanding: 107486916
Market cap (USD): 3817163.555384615
Current ratio: 1.0461297159492797
Quick ratio: 0.7534083186552571
Effective tax rate (%): 24.54905671535868
Interest coverage ratio: 5.142325334042411
COGS to revenue (%): 86.39592242875895
SG&A to revenue (%): 9.907628468410955
Free cash flow (dilution-adjusted): 94481318.68131869
Buyback yield (%): 575.7684117836413
Retained earnings: 572123076.9230769
Inventory turnover: 9.140097429867293
Receivables turnover: 6.390961675066807
Capitalized R&D asset: 0
FCF margin (%): 3.5004934515880026
Revenue growth (%): 12.937182069781755
Rule of 40 score: 16.43767552136976
Financial ratios for OGN.L — annual report dated 2024-07-31
Total revenue: 2223588043.478261
Gross profit: 373952173.91304344
Operating income: 76308695.6521739
Net income: 43943478.26086956
Capital expenditures: 24584782.608695652
Operating cash flow: 618478.2608695652
Depreciation & amortization: 41460869.56521739
Net tangible assets: 104432608.69565217
Owner earnings: 60819565.2173913
Return on net tangible assets (%): 58.23809821186951
Capex to operating income (%): 32.217537462252864
Buffett classification: The Good
Stock price: 0.035897435897435895
P/E ratio: 0.08780608248662389
Shares outstanding: 107486916
Book value: 440141304.347826
P/B ratio: 0.008766513478302995
Market cap (USD): 3858504.6769230766
Debt to equity: 0.6365495270787545
Current ratio: 1.158758002348094
Quick ratio: 0.8429116917351528
Effective tax rate (%): 22.83849295720884
Interest coverage ratio: 3.198068513119533
COGS to revenue (%): 83.18248854549124
SG&A to revenue (%): 12.73499890746497
Free cash flow (dilution-adjusted): -49177173.91304348
Buyback yield (%): 511.2929106333832
Retained earnings: 591886956.5217391
Inventory turnover: 7.459124541931864
Receivables turnover: 4.870264427826941
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.32369255383602
FCF margin (%): -2.2116135251437035
Revenue growth (%): -17.616990386438648
Rule of 40 score: -19.828603911582352
Financial ratios for OGN.L — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 86825000
Buffett classification: The Gruesome
Stock price: 0.032374999999999994
Shares outstanding: 107486916
Book value: 422268750
P/B ratio: 0.008240934015363436
Market cap (USD): 3479888.9054999994
Debt to equity: 0.9822116641751649
Current ratio: 1.4649450261308523
Quick ratio: 0.8715214741363608
Buyback yield (%): 0
Retained earnings: 564225000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OGN.L — annual report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.047466666666666664
Shares outstanding: 107486916
Market cap (USD): 5102045.612799999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — annual report dated 2022-05-31
Total revenue: 0
Operating income: -2222047.244094488
Net income: -874803.1496062992
Capital expenditures: 1436220.4724409448
Operating cash flow: -4527559.05511811
Depreciation & amortization: -95275.5905511811
Net tangible assets: -3366141.7322834646
Owner earnings: -2406299.2125984253
Buffett classification: The Gruesome
Stock price: 0.12598425196850394
Shares outstanding: 401005074
Book value: -3366141.7322834656
Market cap (USD): 50520324.283464566
Debt to equity: 0
Current ratio: 0.37589688234173596
Quick ratio: 0.37589688234173596
Free cash flow (dilution-adjusted): -5228346.456692914
Buyback yield (%): 0
Retained earnings: -64589763.77952756
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — annual report dated 2023-05-31
Total revenue: 0
Operating income: -1477941.1764705882
Net income: -1313970.588235294
Capital expenditures: 2168382.3529411764
Operating cash flow: -2253676.470588235
Depreciation & amortization: -7352.941176470587
Net tangible assets: -4897794.117647058
Owner earnings: -3489705.8823529407
Buffett classification: The Gruesome
Stock price: 0.044117647058823525
Shares outstanding: 401005074
Book value: -4897794.117647057
Market cap (USD): 17691400.32352941
Debt to equity: 0
Current ratio: 0.3293119448495294
Quick ratio: 0.3293119448495294
Free cash flow (dilution-adjusted): -2276470.588235294
Buyback yield (%): 0
Retained earnings: -61629411.76470588
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — annual report dated 2024-05-31
Total revenue: 0
Operating income: -1558394.1605839415
Net income: -2465693.430656934
Capital expenditures: 57664.233576642335
Operating cash flow: -1272262.7737226277
Depreciation & amortization: 12408.75912408759
Net tangible assets: -6301459.854014598
Owner earnings: -2510948.905109489
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 401005074
Book value: -6305839.416058393
Market cap (USD): 20489310.350364964
Debt to equity: 0
Current ratio: 0.13151329389122532
Quick ratio: 0.13151329389122532
Free cash flow (dilution-adjusted): -1329927.00729927
Buyback yield (%): 0
Retained earnings: -63645255.47445255
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — quarterly report dated 2024-11-30
Total revenue: 0
Operating income: -441428.5714285715
Net income: 1535000
Capital expenditures: 0
Operating cash flow: -393571.4285714286
Depreciation & amortization: 3571.4285714285716
Net tangible assets: -4560000
Owner earnings: 1538571.4285714286
Return on net tangible assets (%): -33.7406015037594
Buffett classification: The Gruesome
Stock price: 0.05714285714285715
P/E ratio: 3.732015579339228
Shares outstanding: 401005074
Book value: -4566428.571428571
Market cap (USD): 22914575.65714286
Debt to equity: -0.027217268887846084
Current ratio: 0.13613861386138612
Quick ratio: 0.13613861386138612
Interest coverage ratio: -206
Free cash flow (dilution-adjusted): -393571.4285714286
Buyback yield (%): 0
Retained earnings: -60945714.28571429
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — quarterly report dated 2025-02-28
Total revenue: 0
Operating income: -518750
Net income: -538194.4444444445
Capital expenditures: 0
Operating cash flow: -468055.55555555556
Depreciation & amortization: 4166.666666666667
Net tangible assets: -2900000
Owner earnings: -534027.7777777779
Buffett classification: The Gruesome
Stock price: 0.13194444444444445
Shares outstanding: 401005074
Book value: -2906250
Market cap (USD): 52910391.708333336
Debt to equity: 0
Current ratio: 0.25069587860285536
Quick ratio: 0.25069587860285536
Interest coverage ratio: -149.4
Free cash flow (dilution-adjusted): -609722.2222222222
Buyback yield (%): 0
Retained earnings: -59790972.222222224
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — quarterly report dated 2025-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.12318840579710147
Shares outstanding: 401005074
Market cap (USD): 49399175.7826087
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — annual report dated 2025-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.12318840579710147
Shares outstanding: 401005074
Market cap (USD): 49399175.7826087
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OMI.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -929285.7142857143
Net income: -2732142.8571428573
Capital expenditures: 0
Operating cash flow: -523571.4285714286
Depreciation & amortization: 3571.4285714285716
Net tangible assets: 13359285.714285715
Owner earnings: -2728571.4285714286
Return on net tangible assets (%): -20.42453082393199
Buffett classification: The Gruesome
Stock price: 0.27142857142857146
Shares outstanding: 401005074
Book value: 13363571.42857143
P/B ratio: 8.14484623015661
Market cap (USD): 108844234.37142858
Debt to equity: 0
Current ratio: 3.4721539721539725
Quick ratio: 3.4721539721539725
Interest coverage ratio: -100.07692307692308
Free cash flow (dilution-adjusted): -991428.5714285715
Buyback yield (%): 0
Retained earnings: -58429285.71428572
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.953872467796248
Rule of 40 score: 0
Financial ratios for PHI1.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.852272727272727
Shares outstanding: 971982655
Market cap (USD): 29987873958.238636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHI1.DE — annual report dated 2022-12-31
Total revenue: 18964893617.02128
Gross profit: 7653191489.361703
Operating income: -188297872.34042555
Net income: -1707446808.5106385
Capital expenditures: 19148936.170212768
Operating cash flow: -184042553.19148937
Depreciation & amortization: 1704255319.1489363
Net tangible assets: -547872340.425532
Owner earnings: -22340425.53191497
Buffett classification: The Gruesome
Stock price: 12.819148936170214
Shares outstanding: 971982655
Book value: 14130851063.829788
P/B ratio: 0.8817579607581119
Market cap (USD): 12459990417.819149
Debt to equity: 0.5527365805917338
Current ratio: 1.293042601462062
Quick ratio: 0.7827073355180237
Interest coverage ratio: -0.7254098360655737
COGS to revenue (%): 59.645481572895044
R&D to revenue (%): 11.729399225893308
SG&A to revenue (%): 29.68530880125652
Free cash flow (dilution-adjusted): -1142553191.4893618
Buyback yield (%): 1.5965997046696399
Retained earnings: 7268085106.382979
Inventory turnover: 2.6260805137070884
Receivables turnover: 3.8312916398022785
Capitalized R&D asset: 2224468085.1063833
ROCI (R&D-adjusted, %): 4.8983698933387
FCF margin (%): -6.024569473270882
Rule of 40 score: -6.024569473270882
Financial ratios for PHI1.DE — annual report dated 2023-12-31
Total revenue: 20187777777.77778
Gross profit: 8275555555.555555
Operating income: -186666666.66666666
Net income: -514444444.4444444
Capital expenditures: 100000000
Operating cash flow: 2373333333.3333335
Depreciation & amortization: 1401111111.1111112
Net tangible assets: -1155555555.5555556
Owner earnings: 786666666.6666667
Buffett classification: The Gruesome
Stock price: 21.01111111111111
Shares outstanding: 971982655
Book value: 13401111111.11111
P/B ratio: 1.5239359925420777
Market cap (USD): 20422435562.277775
Debt to equity: 0.604676229168394
Current ratio: 1.1996138064204684
Quick ratio: 0.7783007482500603
Interest coverage ratio: -0.5490196078431372
COGS to revenue (%): 59.00710000550388
R&D to revenue (%): 10.40233364521988
SG&A to revenue (%): 28.24591336892509
Free cash flow (dilution-adjusted): 1560000000
Buyback yield (%): 3.6017033977778743
Retained earnings: 6002222222.222222
Inventory turnover: 3.0710398166714405
Receivables turnover: 4.274053163961422
Capitalized R&D asset: 3590393617.021277
ROCI (R&D-adjusted, %): 1.7438848370222577
Rosenberg metric: 0.2797810723205266
FCF margin (%): 7.727447850734767
Revenue growth (%): 6.448146693841421
Rule of 40 score: 14.175594544576189
Financial ratios for PHI1.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.12222222222222
Shares outstanding: 971982655
Market cap (USD): 29278277530.055553
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHI1.DE — annual report dated 2024-12-31
Total revenue: 18771875000
Gross profit: 8096875000
Operating income: 534375000
Net income: -727083333.3333334
Capital expenditures: 13541666.666666668
Operating cash flow: 1634375000
Depreciation & amortization: 1446875000
Net tangible assets: -1416666666.6666667
Owner earnings: 706250000
Capex to operating income (%): 2.53411306042885
Buffett classification: The Great
Stock price: 23.552083333333332
Shares outstanding: 971982655
Book value: 12544791666.666668
P/B ratio: 1.8248383151664864
Market cap (USD): 22892216489.114582
Debt to equity: 0.6220210910902598
Current ratio: 1.230599214145383
Quick ratio: 0.8379174852652259
Effective tax rate (%): 782.9268292682926
Interest coverage ratio: 1.522255192878338
COGS to revenue (%): 56.866988513401026
R&D to revenue (%): 9.69424560235281
SG&A to revenue (%): 28.122745685589035
Free cash flow (dilution-adjusted): 830208333.3333334
Buyback yield (%): 1.870177141665494
Retained earnings: 3802083333.3333335
Inventory turnover: 3.204502814258912
Receivables turnover: 4.379343863912515
Capitalized R&D asset: 3960866134.7517734
ROCI (R&D-adjusted, %): 1.1927893670268654
Rosenberg metric: -0.08508597883597874
FCF margin (%): 4.422618056711614
Revenue growth (%): -7.013663382684797
Rule of 40 score: -2.591045325973183
Financial ratios for PHI1.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.552083333333332
Shares outstanding: 971982655
Market cap (USD): 22892216489.114582
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHI1.DE — quarterly report dated 2025-03-31
Total revenue: 4453260869.565217
Gross profit: 2009782608.695652
Operating income: 168478260.86956522
Net income: 82608695.6521739
Capital expenditures: 2173913.0434782607
Operating cash flow: -1014130434.7826086
Depreciation & amortization: 300000000
Net tangible assets: -1391304347.826087
Owner earnings: 380434782.6086956
Return on net tangible assets (%): -27.34375
Capex to operating income (%): 1.2903225806451613
Buffett classification: The Great
Stock price: 23.47826086956522
P/E ratio: 69.06192548684211
Shares outstanding: 971982655
Book value: 12747826086.956522
P/B ratio: 1.7901454082537518
Market cap (USD): 22820462334.782608
Debt to equity: 0.6453785811732605
Current ratio: 1.2829658132307238
Quick ratio: 0.7899955601598343
Effective tax rate (%): 25.96153846153846
Interest coverage ratio: 1.8902439024390245
COGS to revenue (%): 54.869416646326584
R&D to revenue (%): 11.154503295093972
SG&A to revenue (%): 30.461313155967783
Free cash flow (dilution-adjusted): -1241304347.826087
Buyback yield (%): 0
Retained earnings: 4052173913.043478
Inventory turnover: 0.6748724106874812
Receivables turnover: 1.178314639056658
Capitalized R&D asset: 496739130.43478256
ROCI (R&D-adjusted, %): 2.202840210220284
FCF margin (%): -27.87405418598975
Rule of 40 score: -27.87405418598975
Financial ratios for PHI1.DE — quarterly report dated 2025-06-30
Total revenue: 5103529411.764706
Gross profit: 2365882352.9411764
Operating income: 471764705.88235295
Net income: 282352941.1764706
Capital expenditures: 2352941.1764705884
Operating cash flow: 455294117.64705884
Depreciation & amortization: 312941176.47058827
Net tangible assets: -1995294117.647059
Owner earnings: 592941176.4705882
Return on net tangible assets (%): -29.71698113207547
Capex to operating income (%): 0.4987531172069826
Buffett classification: The Great
Stock price: 23.152941176470588
P/E ratio: 61.6619802325438
Shares outstanding: 971982655
Book value: 12244705882.35294
P/B ratio: 1.83787650368947
Market cap (USD): 22504257235.764706
Debt to equity: 0.8095695618754806
Current ratio: 1.2585751978891822
Quick ratio: 0.8097486460213861
Effective tax rate (%): 28.18991097922849
Interest coverage ratio: 5.0125
COGS to revenue (%): 53.64223144306133
R&D to revenue (%): 9.266943291839558
SG&A to revenue (%): 28.561549100968193
Free cash flow (dilution-adjusted): 230588235.29411763
Buyback yield (%): 0
Retained earnings: 3569411764.7058825
Inventory turnover: 0.7199876237623762
Receivables turnover: 1.3038773669972947
Capitalized R&D asset: 805756393.8618926
ROCI (R&D-adjusted, %): 2.659518168432363
Rosenberg metric: 0.716874758656198
FCF margin (%): 4.5182111572153065
Revenue growth (%): 14.602076124567478
Rule of 40 score: 19.120287281782787
Financial ratios for PHI1.DE — quarterly report dated 2025-09-30
Total revenue: 5061176470.588236
Gross profit: 2248235294.117647
Operating income: 388235294.11764705
Net income: 220000000
Capital expenditures: 3529411.7647058824
Operating cash flow: 384705882.3529412
Depreciation & amortization: 356470588.2352941
Net tangible assets: -1609411764.7058823
Owner earnings: 572941176.4705882
Return on net tangible assets (%): -35.599415204678365
Capex to operating income (%): 0.9090909090909091
Buffett classification: The Great
Stock price: 26.094117647058823
P/E ratio: 43.35844977454529
Shares outstanding: 971982655
Book value: 12450588235.294117
P/B ratio: 2.037094896333743
Market cap (USD): 25363029750.47059
Debt to equity: 0.7923084191628084
Current ratio: 1.3197724039829302
Quick ratio: 0.8560455192034139
Effective tax rate (%): 31.636363636363633
Interest coverage ratio: 4.23076923076923
COGS to revenue (%): 55.60204556020455
R&D to revenue (%): 9.623430962343097
SG&A to revenue (%): 27.38261273826127
Free cash flow (dilution-adjusted): 161176470.5882353
Buyback yield (%): 0
Retained earnings: 3774117647.0588236
Inventory turnover: 0.7337423312883435
Receivables turnover: 1.2953929539295395
Capitalized R&D asset: 967853324.8081841
ROCI (R&D-adjusted, %): 1.6454529541690106
Rosenberg metric: -0.24875621890547225
FCF margin (%): 3.1845653184565315
Revenue growth (%): -0.8298755186721838
Rule of 40 score: 2.3546897997843477
Financial ratios for PHI1.DE — quarterly report dated 2025-12-31
Total revenue: 5997647058.823529
Gross profit: 2691764705.882353
Operating income: 664705882.3529412
Net income: 468235294.11764705
Capital expenditures: 2352941.1764705884
Operating cash flow: 1636470588.235294
Depreciation & amortization: 327058823.5294118
Net tangible assets: -1038823529.4117647
Owner earnings: 792941176.4705882
Return on net tangible assets (%): -76.33069082672706
Capex to operating income (%): 0.3539823008849558
Buffett classification: The Great
Stock price: 26.223529411764705
P/E ratio: 24.20137677216367
Shares outstanding: 971982655
Book value: 12928235294.11765
P/B ratio: 1.9715618691373187
Market cap (USD): 25488815741.117645
Debt to equity: 0.7108017108017107
Current ratio: 1.322327253361736
Quick ratio: 0.9402210091865264
Effective tax rate (%): 15.879828326180256
Interest coverage ratio: 10.089285714285714
COGS to revenue (%): 55.11965476657513
R&D to revenue (%): 8.375833660258925
SG&A to revenue (%): 25.59827383287564
Free cash flow (dilution-adjusted): 1375294117.647059
Buyback yield (%): 0
Retained earnings: 4205882352.9411764
Inventory turnover: 0.9790940766550522
Receivables turnover: 1.2922686945500632
Capitalized R&D asset: 984752941.1764705
ROCI (R&D-adjusted, %): 2.849854596570439
Rosenberg metric: 0.910628019323671
FCF margin (%): 22.930561004315418
Revenue growth (%): 18.50302185030217
Rule of 40 score: 41.43358285461758
Financial ratios for PHI1.DE — annual report dated 2025-12-31
Total revenue: 20981176470.588234
Gross profit: 9480000000
Operating income: 1704705882.3529413
Net income: 1055294117.6470588
Capital expenditures: 10588235.294117648
Operating cash flow: 1378823529.4117649
Depreciation & amortization: 1322352941.1764705
Net tangible assets: -1038823529.4117647
Owner earnings: 2367058823.529412
Return on net tangible assets (%): -227.85956964892412
Capex to operating income (%): 0.6211180124223603
Buffett classification: The Great
Stock price: 26.223529411764705
P/E ratio: 24.153281360033446
Shares outstanding: 971982655
Book value: 12928235294.11765
P/B ratio: 1.9715618691373187
Market cap (USD): 25488815741.117645
Debt to equity: 0.7108017108017107
Current ratio: 1.322327253361736
Quick ratio: 0.9402210091865264
Effective tax rate (%): 23.85786802030457
Interest coverage ratio: 4.928571428571429
COGS to revenue (%): 54.81664236850959
R&D to revenue (%): 9.53235393069418
SG&A to revenue (%): 27.868117079735345
Free cash flow (dilution-adjusted): 427058823.52941173
Buyback yield (%): 0
Retained earnings: 4205882352.9411764
Inventory turnover: 3.406271777003484
Receivables turnover: 4.520659062103928
Capitalized R&D asset: 3912260416.666667
ROCI (R&D-adjusted, %): 6.466730145915843
Rosenberg metric: 0.760045792787636
FCF margin (%): 2.0354379275541103
Revenue growth (%): 11.769210430967785
Rule of 40 score: 13.804648358521895
Financial ratios for PRIO3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.6210526315789475
Shares outstanding: 798083501
Market cap (USD): 2889902361.5157895
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 1842369.8384201077
Rule of 40 score: 0
Financial ratios for PRIO3.SA — annual report dated 2022-12-31
Total revenue: 227921554.99242422
Gross profit: 152479779.0681818
Operating income: 140267598.5435606
Net income: 122747960.71401516
Capital expenditures: 133622836.21401516
Operating cash flow: 176476805.6723485
Depreciation & amortization: 30597017.4905303
Net tangible assets: 252799683.5473485
Owner earnings: 19722141.990530312
Return on net tangible assets (%): 7.801489983604518
Capex to operating income (%): 95.2627959710297
Buffett classification: The Gruesome
Stock price: 7.0493358633776095
P/E ratio: 45.83341843598463
Shares outstanding: 798083501
Book value: 354303882.1780303
P/B ratio: 15.878907707656259
Market cap (USD): 5625958645.569261
Debt to equity: 0.9233148305370251
Current ratio: 7.640216928280362
Quick ratio: 7.313480416587839
Effective tax rate (%): 6.410691951516137
Interest coverage ratio: 9.83086361795027
COGS to revenue (%): 33.09988646170389
R&D to revenue (%): 1.234725055095419
SG&A to revenue (%): 1.6954572774117544
Free cash flow (dilution-adjusted): 41533391.041666664
Buyback yield (%): 0.011862529496434826
Inventory turnover: 4.645317307161261
Receivables turnover: 38.26411270717277
Capitalized R&D asset: 4048592.3371960176
ROCI (R&D-adjusted, %): 20.76669165531642
FCF margin (%): 18.222669217506514
Rule of 40 score: 18.222669217506514
Financial ratios for PRIO3.SA — annual report dated 2023-12-31
Total revenue: 505779203.1793815
Gross profit: 325384378.12577325
Operating income: 294790216
Net income: 220065451.5546392
Capital expenditures: 566030702.6680413
Operating cash flow: 328841890.6948454
Depreciation & amortization: 87287928.21237114
Net tangible assets: 125898525.02474228
Owner earnings: -258677322.90103102
Return on net tangible assets (%): -205.46493523271562
Capex to operating income (%): 192.0113599252023
Buffett classification: The Gruesome
Stock price: 9.534161490683228
P/E ratio: 34.5763359392859
Shares outstanding: 798083501
Book value: 589611190.7463917
P/B ratio: 12.905211266345722
Market cap (USD): 7609056981.58385
Debt to equity: 0.6884428041496566
Current ratio: 1.5286267062454044
Quick ratio: 1.3404954831558722
Effective tax rate (%): 15.148512483485419
Interest coverage ratio: 10.340596372936758
COGS to revenue (%): 35.666714629551265
R&D to revenue (%): 0.993139447397098
SG&A to revenue (%): 1.192772036724723
Free cash flow (dilution-adjusted): -241029236.9546392
Buyback yield (%): 0.2962784328458116
Inventory turnover: 6.51596790323585
Receivables turnover: 6.828277863276972
Capitalized R&D asset: 7516591.875638336
ROCI (R&D-adjusted, %): 27.897426071015495
Rosenberg metric: 61.439954440008265
FCF margin (%): -47.655031175561184
Revenue growth (%): 121.909333321367
Rule of 40 score: 74.25430214580581
Financial ratios for PRIO3.SA — quarterly report dated 2024-09-30
Operating income: 230335911.60220996
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.979742173112339
Shares outstanding: 798083501
Market cap (USD): 6368500570.594843
Buyback yield (%): 0
Retained earnings: 113579738.2578269
Capitalized R&D asset: 146408.83977900553
ROCI (R&D-adjusted, %): 157390.44025157232
Rule of 40 score: 0
Financial ratios for PRIO3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.486268174474959
Shares outstanding: 798083501
Market cap (USD): 5176583613.109854
Buyback yield (%): 0
Capitalized R&D asset: 6746152.175079118
Rule of 40 score: 0
Financial ratios for PRIO3.SA — annual report dated 2024-12-31
Total revenue: 375953382.0161813
Gross profit: 190449349.10355988
Operating income: 175794274.05016184
Net income: 269689937.907767
Capital expenditures: 387495044.8932039
Operating cash flow: 253141384.8721683
Depreciation & amortization: 65299190.569579296
Net tangible assets: 246655305.85113272
Owner earnings: -52505916.41585761
Return on net tangible assets (%): -21.287162761277568
Capex to operating income (%): 220.42529370588858
Buffett classification: The Gruesome
Stock price: 6.486268174474959
P/E ratio: 19.194574529807735
Shares outstanding: 798083501
Book value: 678679977.7443365
P/B ratio: 7.627429396568863
Market cap (USD): 5176583613.109854
Debt to equity: 0.8081422171217099
Current ratio: 2.1560777389965673
Quick ratio: 1.8294511181200148
Effective tax rate (%): -61.946443699581955
Interest coverage ratio: 6.254536529911147
COGS to revenue (%): 49.34229662097282
R&D to revenue (%): 2.017223180585758
SG&A to revenue (%): 1.348643407872846
Free cash flow (dilution-adjusted): -136543148.55825242
Buyback yield (%): 0.47795143347986613
Inventory turnover: 5.881644565036488
Receivables turnover: 15.412229413131506
Capitalized R&D asset: 11877978.43517499
ROCI (R&D-adjusted, %): 12.965400034947644
Rosenberg metric: -26.862937803043053
FCF margin (%): -36.3191701657243
Revenue growth (%): -25.668477538637685
Rule of 40 score: -61.98764770436199
Financial ratios for PRIO3.SA — quarterly report dated 2025-03-31
Total revenue: 130851736.11111112
Gross profit: 41061458.333333336
Operating income: 28415972.222222224
Net income: 61271354.16666667
Capital expenditures: 50195486.11111111
Operating cash flow: 48845312.5
Depreciation & amortization: 46099479.16666667
Net tangible assets: 356581660.4756944
Owner earnings: 57175347.22222223
Return on net tangible assets (%): 16.03429271879771
Capex to operating income (%): 176.64532368826218
Buffett classification: The Gruesome
Stock price: 6.909722222222222
P/E ratio: 22.50046280619285
Shares outstanding: 798083501
Book value: 801688051.7118056
P/B ratio: 6.8786547214639056
Market cap (USD): 5514535302.048612
Debt to equity: 0.788093860261784
Current ratio: 3.193662360982071
Quick ratio: 2.7419766838990323
Effective tax rate (%): -258.48307245375776
Interest coverage ratio: 3.0497307570478305
COGS to revenue (%): 68.61985973310547
R&D to revenue (%): 0
SG&A to revenue (%): 1.6186682871039901
Free cash flow (dilution-adjusted): -1653472.2222222225
Buyback yield (%): 0.13521084899447566
Retained earnings: 62459709.42013889
Inventory turnover: 2.5400039649299235
Receivables turnover: 2.463772958794255
Capitalized R&D asset: 4502513.946253286
ROCI (R&D-adjusted, %): 1.6579323439975264
FCF margin (%): -1.2636226857687216
Rule of 40 score: -1.2636226857687216
Financial ratios for PRIO3.SA — quarterly report dated 2025-06-30
Total revenue: 110785738.8448905
Gross profit: 17130660.05109489
Operating income: 1010617.4598540145
Net income: 22660375.80656934
Capital expenditures: 117198958.16240875
Operating cash flow: 69122531.94525547
Depreciation & amortization: 45677213.03102189
Net tangible assets: 362676838.9124087
Owner earnings: -48861369.32481752
Return on net tangible assets (%): -13.472426160805432
Capex to operating income (%): 11596.767601792508
Buffett classification: The Gruesome
Stock price: 7.737226277372262
P/E ratio: 73.5711349860596
Shares outstanding: 798083501
Book value: 871590160.6478101
P/B ratio: 7.084697503795722
Market cap (USD): 6174952635.474452
Debt to equity: 0.8587039522868759
Current ratio: 1.5362268278944549
Quick ratio: 1.2750313318083442
Interest coverage ratio: 0.08849431120780477
COGS to revenue (%): 84.53712523858393
R&D to revenue (%): 1.8141811712900227
SG&A to revenue (%): 1.4670096370471821
Free cash flow (dilution-adjusted): -48933638.16423357
Buyback yield (%): 0.0825187636564984
Retained earnings: 91661442.18613139
Inventory turnover: 1.8258389738491054
Receivables turnover: 2.423939368560996
Capitalized R&D asset: 4203713.237899511
ROCI (R&D-adjusted, %): 0.008134782968038335
FCF margin (%): -44.16961846754016
Revenue growth (%): -15.334910993601051
Rule of 40 score: -59.50452946114121
Financial ratios for PRIO3.SA — quarterly report dated 2025-09-30
Total revenue: 125782157.80075188
Gross profit: 29392703.96992481
Operating income: 17948803.216165412
Net income: 12309811.37593985
Capital expenditures: 58199779.43421052
Operating cash flow: 57698828.04887218
Depreciation & amortization: 44409709.22556391
Net tangible assets: 405561201.44360894
Owner earnings: -1480258.832706757
Return on net tangible assets (%): -0.36499024744914577
Capex to operating income (%): 324.25437358293317
Buffett classification: The Gruesome
Stock price: 7.167293233082707
P/E ratio: 59.434817813225294
Shares outstanding: 798083501
Book value: 915967908.6729324
P/B ratio: 6.244867775378307
Market cap (USD): 5720098476.152256
Debt to equity: 1.052437251591357
Current ratio: 2.206175271084205
Quick ratio: 1.9970593793069806
Interest coverage ratio: 1.2117499297838292
COGS to revenue (%): 76.63205618042822
SG&A to revenue (%): 1.4470618415576872
Free cash flow (dilution-adjusted): -1195856.4530075188
Buyback yield (%): 0.029851805459152742
Retained earnings: 109506610.62969923
Inventory turnover: 2.1124670901678857
Receivables turnover: 2.093222942780525
Capitalized R&D asset: 1346602.1897810218
ROCI (R&D-adjusted, %): 0.9134051498480393
Rosenberg metric: 6.100962472779006
FCF margin (%): -0.9507361567940683
Revenue growth (%): 13.536416430690274
Rule of 40 score: 12.585680273896205
Financial ratios for PRIO3.SA — annual report dated 2025-12-31
Total revenue: 519015243.3138686
Gross profit: 103740269.77189781
Operating income: 49081236.75182481
Net income: 74984273.63868614
Capital expenditures: 572671013.0310218
Operating cash flow: 272149625.1788321
Depreciation & amortization: 195028138.26459855
Net tangible assets: 176433929.83029196
Owner earnings: -302658601.12773716
Return on net tangible assets (%): -171.54217526008634
Capex to operating income (%): 1166.7819536143418
Buffett classification: The Gruesome
Stock price: 7.436265709156194
P/E ratio: 79.14674215724804
Shares outstanding: 798083501
Book value: 858584801.9270072
P/B ratio: 6.912259520794741
Market cap (USD): 5934760971.529623
Debt to equity: 1.0766407727017153
Current ratio: 1.8191494718752652
Quick ratio: 1.2281864400799527
Interest coverage ratio: 1.056492452598203
COGS to revenue (%): 80.01209577050183
SG&A to revenue (%): 1.5282123413528026
Free cash flow (dilution-adjusted): -302878077.46350366
Buyback yield (%): 0.24849937637586994
Inventory turnover: 4.009419152770383
Receivables turnover: 9.220732501092867
Capitalized R&D asset: 6738779.194608482
ROCI (R&D-adjusted, %): 2.279343916683344
Rosenberg metric: -11.433432411659803
FCF margin (%): -58.356297115601585
Revenue growth (%): 38.05308534012066
Rule of 40 score: -20.303211775480925
Financial ratios for PRIO3.SA — quarterly report dated 2025-12-31
Total revenue: 130669421.01459852
Gross profit: 9560192.596715327
Operating income: -7436871.461678832
Net income: -31325063.68978102
Capital expenditures: 346211320.089416
Operating cash flow: 95671844.1058394
Depreciation & amortization: 57782922.84671532
Net tangible assets: 176433929.83029196
Owner earnings: -319753460.9324817
Return on net tangible assets (%): -181.23127520882505
Buffett classification: The Gruesome
Stock price: 7.436265709156194
P/E ratio: 91.42148781805837
Shares outstanding: 798083501
Book value: 858584801.9270072
P/B ratio: 6.912259520794741
Market cap (USD): 5934760971.529623
Debt to equity: 1.0766407727017153
Current ratio: 1.8191494718752652
Quick ratio: 1.2281864400799527
Interest coverage ratio: -0.7857651718021137
COGS to revenue (%): 92.68368029606006
SG&A to revenue (%): 1.5417493959041992
Free cash flow (dilution-adjusted): -251045542.16240877
Buyback yield (%): 0.002652609584048554
Inventory turnover: 1.1692918931573764
Receivables turnover: 2.3214496929903574
Capitalized R&D asset: 663251.8248175182
ROCI (R&D-adjusted, %): -0.4130096350867068
FCF margin (%): -192.12264064012476
Revenue growth (%): 3.885497990572256
Rule of 40 score: -188.2371426495525
Financial ratios for PRME — annual report dated 2022-12-31
Total revenue: 0
Operating income: -116544000
Net income: -121821000
Capital expenditures: 16095000
Operating cash flow: -131827000
Depreciation & amortization: 2224000
Net tangible assets: 316270000
Owner earnings: -135692000
Return on net tangible assets (%): -42.903847977993486
Buffett classification: The Gruesome
Stock price: 18.58
Shares outstanding: 180617451
Book value: 316270000
P/B ratio: 10.610782684351976
Market cap (USD): 3355872239.58
Debt to equity: 0.09088753280424954
Current ratio: 11.10346634723366
Quick ratio: 11.10346634723366
Free cash flow (dilution-adjusted): -154381000
Buyback yield (%): 0
Retained earnings: -293197000
Capitalized R&D asset: 86725000
ROCI (R&D-adjusted, %): -13.971886833600983
Rule of 40 score: 0
Financial ratios for PRME — annual report dated 2023-12-31
Total revenue: 0
Operating income: -191292000
Net income: -198133000
Capital expenditures: 8724000
Operating cash flow: -165412000
Depreciation & amortization: 4653000
Net tangible assets: 133071000
Owner earnings: -202204000
Return on net tangible assets (%): -151.95196549210573
Buffett classification: The Gruesome
Stock price: 8.86
Shares outstanding: 180617451
Book value: 133071000
P/B ratio: 12.025690164348354
Market cap (USD): 1600270615.86
Debt to equity: 0.1024490685423571
Current ratio: 2.534002091345728
Quick ratio: 2.534002091345728
Free cash flow (dilution-adjusted): -188046000
Buyback yield (%): 0
Retained earnings: -491330000
Capitalized R&D asset: 206010750
ROCI (R&D-adjusted, %): -35.40573100734847
Rule of 40 score: 0
Financial ratios for PRME — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.87
Shares outstanding: 180617451
Market cap (USD): 698989535.37
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRME — annual report dated 2024-12-31
Total revenue: 2983000
Operating income: -202467000
Net income: -195882000
Capital expenditures: 7294000
Operating cash flow: -122865000
Depreciation & amortization: 6128000
Net tangible assets: 153149000
Owner earnings: -197048000
Return on net tangible assets (%): -128.66424201268046
Buffett classification: The Gruesome
Stock price: 2.92
Shares outstanding: 180617451
Book value: 153149000
P/B ratio: 3.44372445735852
Market cap (USD): 527402956.92
Debt to equity: 0.26636804680409276
Current ratio: 5.581675930560312
Quick ratio: 5.581675930560312
COGS to revenue (%): 0
R&D to revenue (%): 5205.7995306738185
SG&A to revenue (%): 1681.562185719075
Free cash flow (dilution-adjusted): -156227000
Buyback yield (%): 0
Retained earnings: -687212000
Capitalized R&D asset: 283004600
ROCI (R&D-adjusted, %): -32.65145656191964
FCF margin (%): -5237.244384847469
Rule of 40 score: -5237.244384847469
Financial ratios for PRME — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.92
Shares outstanding: 180617451
Market cap (USD): 527402956.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRME — quarterly report dated 2025-03-31
Total revenue: 1454000
Operating income: -52392000
Net income: -51890000
Capital expenditures: 2422000
Operating cash flow: -48857000
Depreciation & amortization: 1700000
Net tangible assets: 106924000
Owner earnings: -52612000
Return on net tangible assets (%): -49.20504283416258
Buffett classification: The Gruesome
Stock price: 1.99
Shares outstanding: 180617451
Book value: 106924000
P/B ratio: 3.3615346179529384
Market cap (USD): 359428727.49
Debt to equity: 1.1330571246866934
Current ratio: 4.776160755949603
Quick ratio: 4.776160755949603
COGS to revenue (%): 0
R&D to revenue (%): 2789.6836313617605
SG&A to revenue (%): 913.6176066024759
Free cash flow (dilution-adjusted): -56960000
Buyback yield (%): 0
Retained earnings: -739102000
Receivables turnover: 85.52941176470588
Capitalized R&D asset: 40562000
ROCI (R&D-adjusted, %): -7.580102281346461
FCF margin (%): -3917.4690508940857
Rule of 40 score: -3917.4690508940857
Financial ratios for PRME — quarterly report dated 2025-06-30
Total revenue: 1115000
Operating income: -53377000
Net income: -52591000
Capital expenditures: 1572000
Operating cash flow: -41412000
Depreciation & amortization: 1864000
Net tangible assets: 60860000
Owner earnings: -52299000
Return on net tangible assets (%): -85.93328951692408
Buffett classification: The Gruesome
Stock price: 2.47
Shares outstanding: 180617451
Book value: 60860000
P/B ratio: 7.330350048800526
Market cap (USD): 446125103.97
Debt to equity: 1.967400591521525
Current ratio: 3.5558650209622096
Quick ratio: 3.5558650209622096
COGS to revenue (%): 0
R&D to revenue (%): 3710.762331838565
SG&A to revenue (%): 1176.4125560538116
Free cash flow (dilution-adjusted): -49309000
Buyback yield (%): 0
Retained earnings: -791693000
Receivables turnover: 9.291666666666666
Capitalized R&D asset: 68551540
ROCI (R&D-adjusted, %): -12.54239597397841
FCF margin (%): -4422.331838565023
Revenue growth (%): -23.31499312242091
Rule of 40 score: -4445.646831687443
Financial ratios for PRME — quarterly report dated 2025-09-30
Total revenue: 1225000
Operating income: -53973000
Net income: -50582000
Capital expenditures: 247000
Operating cash flow: -35039000
Depreciation & amortization: 1881000
Net tangible assets: 161821000
Owner earnings: -48948000
Return on net tangible assets (%): -30.24823724980071
Buffett classification: The Gruesome
Stock price: 5.54
Shares outstanding: 180617451
Book value: 161821000
P/B ratio: 6.183503244572707
Market cap (USD): 1000620678.54
Debt to equity: 0.7300350387156179
Current ratio: 6.608012793055199
Quick ratio: 6.608012793055199
COGS to revenue (%): 0
R&D to revenue (%): 3591.0204081632655
SG&A to revenue (%): 914.9387755102041
Free cash flow (dilution-adjusted): -48033000
Buyback yield (%): 0
Retained earnings: -842275000
Capitalized R&D asset: 85096710
ROCI (R&D-adjusted, %): -11.942058263493905
FCF margin (%): -3921.0612244897957
Revenue growth (%): 9.865470852017937
Rule of 40 score: -3911.1957536377777